Polysaccharide-coated porous starch-based oral carrier for paclitaxel: Adsorption and sustained release in colon

A porous starch-based carrier coated with chitosan-phytic acid was designed for oral administration to improve drug delivery to the colon. Using hydrophobic paclitaxel as a model drug, improved drug loading (15.12% +/- 0.31%) and entrapment efficiency (86.63 +/- 1.30%) of porous starch were achieved by size/shape matching and adsorption force. Fluorescent paclitaxel particles inside starch were captured clearly. Furthermore, chitosan-phytic acid was added as a second protection since porous starch showed a dissolution rate of only 14.98-20.27% during the simulated digestion in stomach and small intestine, which was far lower than that of raw paclitaxel in porous starch (59.65 +/- 2.57%). The release curve in the colon was also obtained and showed that 86.98 +/- 2.90% of the drug was released. Finally, we verified the non-covalent interactions between starch and paclitaxel. This showed that the retention of paclitaxel into porous starch decreased once hydrogen bonding stopped. The hydrophobic CH-pi effect provides a binding complementing contribution.

Automated summary

A porous starch-based carrier coated with chitosan-phytic acid was developed to enhance drug delivery to the colon. The results showed improved drug loading and entrapment efficiency by size/shape matching and adsorption force. Chitosan-phytic acid provided a second protection and enhanced drug release in the colon. The study also confirmed non-covalent interactions between starch and the drug.